Aluminum-triggered structural modifications and aggregation of beta-amyloids.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cellular and molecular life sciences : CMLS

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 15990957PMCID PMC11139087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease

  2004cited by this paper
• Aluminium in Alzheimer’s disease: are we still at a crossroad?

  2004cited by this paper
• Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes.

  2004cited by this paper
• The metallobiology of Alzheimer's disease.

  2003cited by this paper
• Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• The galvanization of β-amyloid in Alzheimer's disease

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase.

  2002cited by this paper
• Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein.

  2001cited by this paper
• Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

  2001cited by this paper
• Profile of changes in lipid bilayer structure caused by beta-amyloid peptide.

  2001cited by this paper
• Stabilization of Partially Folded Conformation during α-Synuclein Oligomerization in Both Purified and Cytosolic Preparations*

  2001cited by this paper
• Causes of Alzheimer's disease.

  2000cited by this paper
• Review: modulating factors in amyloid-beta fibril formation.

  2000cited by this paper
• Aggresomes, inclusion bodies and protein aggregation.

  2000cited by this paper
• The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.

  2000cited by this paper
• Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide.

  2000cited by this paper
• Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

  2000cited by this paper
• Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence.

  1999cited by this paper
• Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.

  1999cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.

  1999cited by this paper
• Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.

  1999cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques.

  1998cited by this paper
• Aluminosilicate Particulate and Beta‐Amyloid in Vitro Interactions: A Model of Alzheimer Plaque Formation

  1998cited by this paper
• Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis*

  1998cited by this paper
• Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes.

  1997cited by this paper
• Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

  1997cited by this paper
• Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity.

  1994cited by this paper
• Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro.

  1994cited by this paper
• Activation of acetylcholinesterase by aluminium(III): the relevance of the metal species.

  1994cited by this paper
• An interaction of beta-amyloid with aluminium in vitro.

  1993cited by this paper
• Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide

  1993cited by this paper
• Deposition of aluminum in brain tissues of rats exposed to inhalation of aluminum acetylacetonate.

  1993cited by this paper
• Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.

  1993cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

  1993cited by this paper
• Aluminium in Alzheimer's?

  1993cited by this paper
• Toxic effects of aluminium on nerve cells and synaptic transmission.

  1993cited by this paper
• Quantitative analysis of protein far UV circular dichroism spectra by neural networks.

  1992cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper
• Vesicles of variable diameter prepared by a modified injection method.

  1977cited by this paper

• Effects of urban particulate matter on the secondary structure of albumin.

  2025cites this paper
• Heavy metals: toxicity and human health effects

  2024cites this paper
• The White Matter Integrity and Functional Connection Differences of Fornix (Cres)/Stria Terminalis in Individuals with Mild Cognitive Impairment Induced by Occupational Aluminum Exposure

  2024cites this paper
• Aggregation Behavior of Amyloid Beta Peptide Depends Upon the Membrane Lipid Composition

  2024cites this paper
• Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases

  2023cites this paper
• Aluminium in the Human Brain: Routes of Penetration, Toxicity, and Resulting Complications

  2023cites this paper
• Assessment of the neuroprotective potential of d-cycloserine and l-serine in aluminum chloride-induced experimental models of Alzheimer’s disease: In vivo and in vitro studies

  2022cites this paper
• Neuroprotective activity of Ipomoea cairica leaf extract against cadmium chloride-induced biochemical changes in the brain of male Wistar rats

  2022cites this paper
• A multifunctional metal regulator as the potential theranostic agent: Design, synthesis, anti-AD activities and metallic ion sensing properties.

  2022cites this paper
• Antioxidant activity and protective effect of the outer scales hydroalcoholic extract of Allium cepa L. var. Tropea on toxicity damage induced by Cadmium in Caco-2 cells.

  2022cites this paper
• Evaluating the Multifunctionality of a New Modulator of Zinc-Induced Aβ Aggregation Using a Novel Computational Approach

  2021cites this paper
• A Toxic Synergy between Aluminium and Amyloid Beta in Yeast

  2021cites this paper
• Monitoring the early aggregatory behaviour and size of Aβ1-42 in the absence & presence of metal ions using dynamic light scattering.

  2021cites this paper
• The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation

  2021cites this paper
• Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.

  2021cites this paper
• Evidence of cadmium and mercury involvement in the Aβ42 aggregation process.

  2020cites this paper
• Novel Insights into Mercury Effects on Hemoglobin and Membrane Proteins in Human Erythrocytes

  2020cites this paper
• “What Doesn’t Kill You Makes You Stronger”: Future Applications of Amyloid Aggregates in Biomedicine

  2020cites this paper
• Modulatory Effects of Ginkgo biloba Against Amyloid Aggregation Through Induction of Heat Shock Proteins in Aluminium Induced Neurotoxicity

  2020cites this paper
• Aluminium toxicosis: a review of toxic actions and effects

  2019cites this paper
• Effects of Metal Ions on Aβ42 Peptide Conformations from Molecular Simulation Studies

  2019cites this paper
• Zn2+ Interaction with Amyloid-B: Affinity and Speciation

  2019cites this paper
• Concentration-dependent effects of mercury and lead on Aβ42: possible implications for Alzheimer’s disease

  2019cites this paper
• Aluminum affects neural phenotype determination of embryonic neural progenitor cells

  2019cites this paper
• Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.

  2019cites this paper
• Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats

  2019cites this paper
• Elucidating the 3D structures of Al(iii)–Aβ complexes: a template free strategy based on the pre-organization hypothesis

  2017cites this paper
• A Combination of Resveratrol and Curcumin is Effective Against Aluminum Chloride-Induced Neuroinflammation in Rats

  2017cites this paper
• Effects of Intrinsic and Extrinsic Factors on Aggregation of Physiologically Important Intrinsically Disordered Proteins.

  2017cites this paper
• Trehalose Inhibits A53T Mutant α-Synuclein Overexpression and Neurotoxicity in Transduced PC12 Cells

  2017cites this paper
• Characterization of plasma metal profiles in Alzheimer’s disease using multivariate statistical analysis

  2017cites this paper
• Hyperforin attenuates aluminum-induced Aβ production and Tau phosphorylation via regulating Akt/GSK-3β signaling pathway in PC12 cells.

  2017cites this paper
• Understanding Aspects of Aluminum Exposure in Alzheimer's Disease Development

  2016cites this paper
• The Aggregation of Aβ42 Induced by Nano Copper and the Antagonistic Action of Polysaccharides

  2015cites this paper
• Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer's disease rat model

  2015cites this paper
• A novel method for expression and purification of authentic amyloid-β with and without (15)N labels.

  2015cites this paper
• Biosensor for Aluminum(III) Based on α-Chymotrypsin Inhibition using a Disposable Screen-Printed Carbon Electrode and Acetyl-Tyrosine Ethyl Ester as Substrate

  2015cites this paper
• The Toxic Effect of Lithium Ion on Neurons (PC12 cells) and Aβ42 Molecules

  2014cites this paper
• Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats

  2014cites this paper
• Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts

  2014cites this paper
• Effects of Aluminium on β-Amyloid (1–42) and Secretases (APP-Cleaving Enzymes) in Rat Brain

  2014cites this paper
• Heavy metals toxicity: effect of cadmium ions on amyloid beta protein 1–42. Possible implications for Alzheimer’s disease

  2014cites this paper
• The missing link in the amyloid cascade of Alzheimer's disease - metal ions.

  2013cites this paper
• Ca(2+) enhances Aβ polymerization rate and fibrillar stability in a dynamic manner.

  2013cites this paper
• β-Amyloid-aluminum complex alters cytoskeletal stability and increases ROS production in cortical neurons.

  2013cites this paper
• Impact of sub-chronic aluminium-maltolate exposure on catabolism of amyloid precursor protein in rats.

  2013cites this paper
• Combining conformational sampling and selection to identify the binding mode of zinc-bound amyloid peptides with bifunctional molecules

  2012cites this paper
• Environmental Factors Preceding Aβ40 Monomer to Oligomers and the Detection of Oligomers in Alzheimer's Disease Patient Serum

  2012cites this paper
• The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.

  2012cites this paper
• Inhibitory effect of curcumin on the Al(III)-induced Aβ₄₂ aggregation and neurotoxicity in vitro.

  2012cites this paper
• Lytic peptides with improved stability and selectivity designed for cancer treatment.

  2012cites this paper
• Aluminium-maltolate-induced impairment of learning, memory and hippocampal long-term potentiation in rats.

  2012cites this paper
• Alzheimer’s Disease and Metal Contamination: Aspects on Genotoxicity

  2011influential citation
• Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases.

  2011cites this paper
• Exploring the reactions of β-amyloid (Aβ) peptide 1-28 with Al(III) and Fe(III) ions.

  2011cites this paper
• Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.

  2011cites this paper
• Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses

  2011cites this paper
• Microarray Analysis on Human Neuroblastoma Cells Exposed to Aluminum, β1–42-Amyloid or the β1–42-Amyloid Aluminum Complex

  2011cites this paper
• Physiological cholesterol concentration is a neuroprotective factor against β-amyloid and β-amyloid-metal complexes toxicity.

  2011cites this paper
• Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.

  2011cites this paper
• Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation.

  2011cites this paper
• Microarray Analysis on Human Neuroblastoma Cells Exposed to Aluminum, Beta 1–42 -Amyloid or the Beta 1–42 -Amyloid Aluminum Complex

  2011cites this paper
• A method to prevent cross contamination during 2‐DE by β‐amyloid peptides

  2010cites this paper
• Recent Development of Bifunctional Small Molecules to Study Metal-Amyloid-β Species in Alzheimer's Disease

  2010cites this paper
• Trace Copper(II) or Zinc(II) Ions Drastically Modify the Aggregation Behavior of Amyloid-β1–42: An AFM Study

  2010cites this paper
• Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape

  2010cites this paper
• Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease

  2010cites this paper
• Aluminium and Iron in Humans: Bioaccumulation, Pathology, and Removal

  2010cites this paper
• The Role of Zinc in Alzheimer's Disease

  2010cites this paper
• The protective effect of Rho-associated kinase inhibitor on aluminum-induced neurotoxicity in rat cortical neurons.

  2010cites this paper
• Aluminum does not enhance beta-amyloid toxicity in rat hippocampal cultures.

  2010cites this paper
• A Lennard-Jones plus Coulomb potential for Al3+ ions in aqueous solutions.

  2010cites this paper
• Metal Ion Physiopathology in Neurodegenerative Disorders

  2009cites this paper
• Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease

  2009cites this paper
• Amyloid-β and aluminum ions enhance neuronal damage mediated by NMDA-activated glutamate receptors

  2009cites this paper
• Chelation therapy for neurodegenerative diseases

  2009cites this paper
• Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease.

  2009cites this paper
• Electrochemical and Conformational Consequences of Copper (CuI and CuII) Binding to β‐Amyloid(1–40)

  2009cites this paper
• Tetrahydroxy stilbene glucoside reduces the cognitive impairment and overexpression of amyloid precursor protein induced by aluminum exposure

  2009cites this paper
• Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments.

  2009cites this paper
• Alzheimer's disease, metal ions and metal homeostatic therapy.

  2009cites this paper
• Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators

  2009cites this paper
• Metal Deficiency Increases Aberrant Hydrophobicity of Mutant Superoxide Dismutases That Cause Amyotrophic Lateral Sclerosis*

  2009cites this paper
• Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents.

  2009cites this paper
• Interaction between Alzheimer's Amyloid-β and Amyloid-β-Metal Complexes with Cell Membranes

  2009cites this paper
• Clioquinol Decreases Amyloid-β Burden and Reduces Working Memory Impairment in a Transgenic Mouse Model of Alzheimer's Disease

  2009cites this paper
• Metal loading capacity of Abeta N-terminus: a combined potentiometric and spectroscopic study of zinc(II) complexes with Abeta(1-16), its short or mutated peptide fragments and its polyethylene glycol-ylated analogue.

  2009cites this paper
• Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.

  2009cites this paper
• Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide

  2008influential citation
• Role of metal ions in the abeta oligomerization in Alzheimer's disease and in other neurological disorders.

  2008cites this paper
• Mutual Stimulation of Beta-Amyloid Fibrillogenesis by Clioquinol and Divalent Metals

  2008cites this paper
• Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease.

  2008cites this paper
• Aluminum Modulates Effects of βAmyloid1–42 on Neuronal Calcium Homeostasis and Mitochondria Functioning and Is Altered in a Triple Transgenic Mouse Model of Alzheimer's Disease

  2008cites this paper
• Amyloid beta conformation in aqueous environment.

  2008cites this paper
• Does neurotransmission impairment accompany aluminium neurotoxicity?

  2007cites this paper
• Protein side chains facilitate Mg/Al exchange in model protein binding sites.

  2007cites this paper
• Interaction entre le zinc(II) et le peptide amyloïde bêta lié à la maladie d'Alzheimer

  2007cites this paper
• Author ' s personal copy Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma

  2007cites this paper
• Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis.

  2007cites this paper
• Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors.

  2007cites this paper